Asthma in South African adolescents: a time trend and risk factor analysis over two decades.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
13
08
2020
accepted:
02
11
2020
entrez:
9
4
2021
pubmed:
10
4
2021
medline:
10
4
2021
Statut:
epublish
Résumé
South Africa has undergone major economic and health system changes, impacting the epidemiology of childhood asthma. This study aimed to investigate prevalence time trends of asthma in South African adolescents over two decades and to identify associated risk factors. A cross-sectional survey was conducted in 2017, in a randomised sample of 13-14-year-old Cape Town adolescents, using the standardised Global Asthma Network written, video and environmental questionnaires. Using time-trend analysis, the prevalence and severity of asthma were compared with data from the 2002 ISAAC phase III study. Environmental and social risk factors were analysed. A total of 3979 adolescents were included. The prevalence of lifetime and current asthma were 34.5% and 21.3%, respectively, on the self-report written questionnaire, similar to 2002 results. The prevalence of severe asthma in the previous 12 months increased, measured by wheeze limiting speech (7.8% to 11.8%), four or more attacks of wheezing (5.0% to 5.8%) or woken by wheeze on one or more nights per week (5.0% to 6.9%). The video questionnaire revealed increases in lifetime (16.9% to 22.5%), current (11.2% to 18.7%) and severe asthma (12.1% to 14.8%). Multivariate analysis showed associations between current asthma and smoking, female sex, pet exposure and higher socioeconomic status. Severe asthma was associated with smoking, pet exposure, outdoor pollution exposure and informal housing; 33% of those with severe or current asthma had been diagnosed. The prevalence of asthma is high, with increasing rates of severe asthma in adolescents. Underdiagnosis is a major concern and reduction in exposure to environmental factors, particularly smoking, and improved socioeconomic development are needed.
Sections du résumé
BACKGROUND
BACKGROUND
South Africa has undergone major economic and health system changes, impacting the epidemiology of childhood asthma. This study aimed to investigate prevalence time trends of asthma in South African adolescents over two decades and to identify associated risk factors.
METHODS
METHODS
A cross-sectional survey was conducted in 2017, in a randomised sample of 13-14-year-old Cape Town adolescents, using the standardised Global Asthma Network written, video and environmental questionnaires. Using time-trend analysis, the prevalence and severity of asthma were compared with data from the 2002 ISAAC phase III study. Environmental and social risk factors were analysed.
RESULTS
RESULTS
A total of 3979 adolescents were included. The prevalence of lifetime and current asthma were 34.5% and 21.3%, respectively, on the self-report written questionnaire, similar to 2002 results. The prevalence of severe asthma in the previous 12 months increased, measured by wheeze limiting speech (7.8% to 11.8%), four or more attacks of wheezing (5.0% to 5.8%) or woken by wheeze on one or more nights per week (5.0% to 6.9%). The video questionnaire revealed increases in lifetime (16.9% to 22.5%), current (11.2% to 18.7%) and severe asthma (12.1% to 14.8%). Multivariate analysis showed associations between current asthma and smoking, female sex, pet exposure and higher socioeconomic status. Severe asthma was associated with smoking, pet exposure, outdoor pollution exposure and informal housing; 33% of those with severe or current asthma had been diagnosed.
CONCLUSION
CONCLUSIONS
The prevalence of asthma is high, with increasing rates of severe asthma in adolescents. Underdiagnosis is a major concern and reduction in exposure to environmental factors, particularly smoking, and improved socioeconomic development are needed.
Identifiants
pubmed: 33834055
doi: 10.1183/23120541.00576-2020
pii: 00576-2020
pmc: PMC8021807
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright ©ERS 2021.
Déclaration de conflit d'intérêts
Conflict of interest: C.B. Baard reports grants from the South African Medical Research Council and a grant from the Allergy Society of South Africa during the conduct of the study. Conflict of interest: Z. Franckling-Smith reports grants from the South African Medical Research Council and a grant from the Allergy Society of South Africa during the conduct of the study. Conflict of interest: J. Munro reports grants from the South African Medical Research Council and a grant from the Allergy Society of South Africa during the conduct of the study. Conflict of interest: L. Workman reports grants from the South African Medical Research Council and a grant from the Allergy Society of South Africa during the conduct of the study. Conflict of interest: H.J. Zar reports grants from the South African Medical Research Council and a grant from the Allergy Society of South Africa during the conduct of the study.
Références
S Afr Med J. 2011 Jun 27;101(7):472-6
pubmed: 21920101
S Afr Med J. 2016 Mar 09;106(4):57
pubmed: 27032860
Curr Opin Allergy Clin Immunol. 2017 Jun;17(3):188-193
pubmed: 28333691
Pediatr Pulmonol. 2017 Feb;52(2):154-159
pubmed: 27377853
Environ Pollut. 2018 Feb;233:529-539
pubmed: 29102883
J Allergy Clin Immunol. 2020 Jan;145(1):415-426
pubmed: 31606483
Pediatr Allergy Immunol. 2007 Nov;18(7):560-5
pubmed: 18001427
Lancet. 2008 Sep 20;372(9643):1058-64
pubmed: 18805334
Int J Tuberc Lung Dis. 2014 Nov;18(11):1269-78
pubmed: 25299857
Pediatr Pulmonol. 2018 Nov;53(11):1475-1484
pubmed: 30238644
Gend Med. 2007;4 Suppl B:S133-46
pubmed: 18156099
Clin Allergy. 1979 Jul;9(4):319-4
pubmed: 476905
Environ Health. 2014 May 06;13(1):32
pubmed: 24885606
Eur Respir J. 2002 May;19(5):892-8
pubmed: 12030730
Thorax. 2009 Jun;64(6):476-83
pubmed: 19237391
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):85-90
pubmed: 24565774
Soc Sci Med. 2008 Apr;66(8):1828-40
pubmed: 18299167
Int J Tuberc Lung Dis. 2005 Jan;9(1):10-6
pubmed: 15675544
Respir Med. 2016 Dec;121:21-25
pubmed: 27888987
Int J Epidemiol. 1996 Jun;25(3):609-16
pubmed: 8671563
SAJCH. 2013 Jul 31;7(4):127-134
pubmed: 25741408
Pediatr Pulmonol. 2007 Aug;42(8):683-92
pubmed: 17595039
Pediatr Allergy Immunol. 2003 Oct;14(5):383-93
pubmed: 14641609
Paediatr Drugs. 2012 Dec 1;14(6):353-9
pubmed: 22978815
Allergol Immunopathol (Madr). 2013 Mar-Apr;41(2):73-85
pubmed: 22771150
Lancet. 2012 Dec 8;380(9858):2029-43
pubmed: 23201214
Health Econ Policy Law. 2020 Jan;15(1):43-55
pubmed: 29996951
J Allergy Clin Immunol. 2005 Oct;116(4):773-9
pubmed: 16210050
Lancet. 2006 Aug 26;368(9537):733-43
pubmed: 16935684